Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-60
Closed -$563 2535
2025
Q3
$563 Buy
+60
New +$559 ﹤0.01% 2409
2024
Q4
Sell
-4,700
Closed -$24.7K 2433
2024
Q3
$24.7K Buy
4,700
+4,177
+799% +$23.3K ﹤0.01% 1862
2024
Q2
$2.84K Buy
523
+226
+76% +$1.15K ﹤0.01% 2359
2024
Q1
$1.61K Sell
297
-43
-13% -$274 ﹤0.01% 1861
2023
Q4
$3K Buy
340
+245
+258% +$1.61K ﹤0.01% 1975
2023
Q3
$1K Buy
+95
New +$844 ﹤0.01% 1878
2023
Q2
Sell
-882
Closed -$16K 1994
2023
Q1
$16K Buy
882
+46
+6% +$798 ﹤0.01% 1438
2022
Q4
$16K Buy
836
+337
+68% +$6.77K ﹤0.01% 1365
2022
Q3
$9K Buy
499
+137
+38% +$2.99K ﹤0.01% 1357
2022
Q2
$7K Buy
+362
New +$6.55K ﹤0.01% 1312

Other funds holding ADTN

Blue Trust Inc's ADTN Position: Q4 2025 in Review

Blue Trust Inc sold out of Adtran (ADTN) in Q4 2025, closing a stake of 60 shares — an estimated $563 sold.

Blue Trust Inc first reported a position in ADTN in Q2 2022 and held it in 10 quarters. The position peaked at $24.7K in Q3 2024. 213 funds tracked by Wall St. Rank hold ADTN as of Q4 2025.

  • Blue Trust Inc reported no remaining Adtran position as of Q4 2025 after selling out during the quarter.
  • Blue Trust Inc sold 60 Adtran shares in Q4 2025, an estimated $563.
  • Blue Trust Inc first reported a position in Adtran in Q2 2022 and held it in 10 quarters.
  • Blue Trust Inc's Adtran position peaked at $24.7K in Q3 2024.
  • 213 funds tracked by Wall St. Rank held Adtran as of Q4 2025.

Based on Blue Trust Inc's 13F filing for Q4 2025, filed 16 Jan 2026.